Related Experiment Video
Updated: May 28, 2026
09:52
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Immunotherapy of aspergillosis
A Carvalho1, C Cunha, F Bistoni
1Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy.
Summary
Novel immunotherapies, including immune function modulation and vaccination, show promise for invasive aspergillosis in high-risk patients. Integrating genetic data may optimize these antifungal strategies for better outcomes.
Area of Science:
- Immunology
- Infectious Diseases
- Medical Genetics
Background:
- Invasive aspergillosis poses a significant challenge in immunocompromised patients.
- Current treatments for invasive aspergillosis are limited, necessitating new therapeutic approaches.
- Enhancing or restoring antifungal immunity is crucial for managing these infections.
Purpose of the Study:
- To explore novel immunotherapeutic strategies for invasive aspergillosis.
- To investigate the role of modulating innate immune functions and vaccination.
- To assess the impact of individual genetic profiles on immunotherapy outcomes.
Main Methods:
- Review of recent findings on immunotherapeutic strategies.
- Analysis of the contribution of genetic profiles to treatment efficacy.
- Exploration of integrating immunological and genetic data.
Main Results:
- Modulation of innate immune functions and vaccination are identified as promising immunotherapies.
- Individual genetic profiles may influence immunotherapy outcomes.
- Integration of immunological and genetic data is suggested for optimization.
Conclusions:
- Novel immunotherapeutic strategies are needed for invasive aspergillosis.
- Combining immunological and genetic insights can refine treatment approaches.
- Optimized strategies could improve fungal infection management in high-risk settings.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...